Achieve functional knockout in up to 90% of human primary T cells

Maximize gene editing in human primary T cells with up to 90% knockout efficiency using TrueCut Cas9 Protein v2 and TrueGuide Synthetic gRNA. Discover a complete CRISPR-Cas9 workflow from T cell isolation to NGS validation.